RxBio Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $252K

  • Investors
  • 2

RxBio General Information

Description

Developer of novel drugs designed for use in the mitigation of acute radiation syndrome (ARS). The company specializes in developing drugs to mitigate gastrointestinal acute radiation syndrome and also protect against lethal whole-body gastrointestinal tract, damage to the gastrointestinal tract due to radiation, chemotherapy, and various toxins, enabling the medical community and patients to combat chronic conditions effectively.

Contact Information

Website
www.rxbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PO Box 5389
  • Johnson City, TN 37602-5389
  • United States
+1 (423)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • PO Box 5389
  • Johnson City, TN 37602-5389
  • United States
+1 (423)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RxBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 18-Sep-2020 $252K Completed Generating Revenue
7. Later Stage VC 21-Jul-2017 Completed Generating Revenue
6. Grant 01-Jan-2015 Completed Generating Revenue
5. Grant 01-Jan-2013 Completed Generating Revenue
4. Grant 01-Jan-2011 Completed Generating Revenue
3. Seed Round 29-Sep-2010 Completed Generating Revenue
2. Grant 01-Jan-2008 $197K Completed Generating Revenue
1. Grant 01-Jan-2007 $97.2K Completed Generating Revenue
To view RxBio’s complete valuation and funding history, request access »

RxBio Patents

RxBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2935677-C Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Active 30-Dec-2013
CA-2935677-A1 Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Active 30-Dec-2013
US-9567288-B2 Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Active 30-Dec-2013
US-20170226139-A1 Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Inactive 30-Dec-2013
US-20150183726-A1 Crystalline salts of (z)-o-octadec-9-en-1-yl o,o-dihydrogen phosphorothioate Active 30-Dec-2013 C07C229/26
To view RxBio’s complete patent history, request access »

RxBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RxBio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute Of Allergy and Infectious Diseases Government
U.S. Department of Health and Human Services Government
To view RxBio’s complete investors history, request access »

RxBio FAQs

  • When was RxBio founded?

    RxBio was founded in 2007.

  • Where is RxBio headquartered?

    RxBio is headquartered in Johnson City, TN.

  • What is the size of RxBio?

    RxBio has 8 total employees.

  • What industry is RxBio in?

    RxBio’s primary industry is Drug Discovery.

  • Is RxBio a private or public company?

    RxBio is a Private company.

  • What is RxBio’s current revenue?

    The current revenue for RxBio is .

  • How much funding has RxBio raised over time?

    RxBio has raised $2.24M.

  • Who are RxBio’s investors?

    National Institute Of Allergy and Infectious Diseases and U.S. Department of Health and Human Services have invested in RxBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »